EpiPen – $465 Million Settlement Posted on October 10, 2016 by Jay EpiPen maker Mylan has agreed to a $465 million settlement over claims that Medicaid and Medicare were overcharged for the epinephrine auto-injectors because the product was misclassified. Sen. Amy Klobuchar, D-Minn., questioned whether other drugs are similarly misclassified, leading to overpayment by government programs. The New York Times (free-article access for SmartBrief readers) (10/7)
